NEW YORK, Jan. 2, 2025 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Climb Bio, Inc. (NASDAQ: CLYM) on behalf of the company’s shareholders. The investigation seeks to determine whether Climb Bio’s directors breached their fiduciary duties in connection with…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.